DSGN
Design Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -9.1% ·
share flow +2.4% ·
net new positions -10.0%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 61 | +2 | 14.66M | $212.03M | +5 | −3 |
| Q1 2026 | 61 | +2 | 13.39M | $142.37M | +4 | −2 |
| Q4 2025 | 59 | +1 | 16.55M | $155.25M | +1 | n/a |
| Q3 2025 | 16 | +1 | 10.74M | $80.90M | +1 | n/a |
| Q2 2025 | 12 | -2 | 9.77M | $32.93M | n/a | −2 |
| Q1 2025 | 11 | +2 | 5.33M | $20.59M | +2 | n/a |
| Q4 2024 | 9 | -2 | 5.31M | $32.78M | n/a | −2 |
| Q3 2024 | 10 | -1 | 4.34M | $23.36M | n/a | −1 |
| Q2 2024 | 11 | n/a | 4.24M | $14.20M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 1.60M | +61.6% | $8.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 758.55K | +7.1% | $4.08M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | D. E. Shaw & Co. ✦ | 582.86K | +8.8% | $3.14M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Citadel Advisors ✦ | 575.55K | +88.9% | $3.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 304.24K | -24.4% | $1.64M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 274.00K | -28.7% | $1.47M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 207.26K | -66.1% | $1.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 17.19K | -29.2% | $92,493 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 10.78K | -2.7% | $58,018 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 10 | T. Rowe Price ✦ | 10.28K | 0.0% | $56,000 | 0.0% | Held | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Wellington Management | $859,700 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 124 holders, 37.97M shares, $395.07M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.